# Safety and Efficacy of Intracoronary Ad5FGF-4 in Patients With Stable Angina

> **NCT00185263** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Cardium Therapeutics** · enrollment: 116 (actual)

## Conditions studied

- Stable Angina

## Interventions

- **GENETIC:** AdF5FGF-4 vs. Placebo

## Key facts

- **NCT ID:** NCT00185263
- **Lead sponsor:** Cardium Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-03
- **Primary completion:** 2005-01
- **Final completion:** 2008-11
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2008-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00185263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00185263, "Safety and Efficacy of Intracoronary Ad5FGF-4 in Patients With Stable Angina". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00185263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*